Drug utilization research on type 2 diabetes patients used oral anti-diabetic drugs in cities of China

Chinese Pharmaceutical Journal

Volumn 47, Issue 9, 2012, Pages 736-738

  Ji, Li Nong ^a   Wu, Jing ^a   Chen, Ying Li ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ORAL ANTIDIABETIC AGENT;

ARTICLE; CHINA; DRUG UTILIZATION; NON INSULIN DEPENDENT DIABETES MELLITUS;

EID: 84866489121     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. YANG W Y, LU J M, WENG J P. Prevalence of diabetes among men and women in China[J]. New England J Med, 2010, 362(12): 1090-1101.
2. Chinese Diabetes Society. Chinese guideline for type 2 diabetes mellitus 2010(draft)[S][EB/OL]. http://cdschina.org/guideline.jsp.
3. ZHAO W. The use of oral hypoglycemic drugs based on more than forty hospitals, in Beijing, 2007-2009[J]. J China Pharm, 2010, 21(42): 3951-3953.
4. WANG S J, PENG Y F, XIA P Y. Analysis of the utilization of anti-diabetic drugs based on twenty hospitals in Chongqing[J]. J China Pharm, 2010, 21(42): 3958-3960.
5. ZHOU S P, ZHOU J Z, JIANG J, et al. The metformin is the cornerstone of the treatment status in type 2 diabetes-the interpretation for Global Guideline for Type 2 Diabetes 2005IDF and 2006 ADA/EASD conseusus[J]. Chin Can Pract, 2007, 10(6): 470.
6. LI G R, LI L L, WANG J H. The research for drugs which used in type 2 diabetes treatment[J]. J China Pharm, 2008, 19(5): 383-385.
7. LI Y R, WANG H X, DING S. The clinical studies of gliclazide MR that it can improve vascular functionfor diabetic peripheral vascular patients[J]. Clin Focus, 2009, 24(2): 296.
8. FAN X L. The survey of drugs use and the analysis of adverse reactions for elderly diabetes patients in our hospital[J]. China Mod Med, 2010, 17(12): 136.
9. WENG J P. The timing of insulin therapy for type 2 diabetes[J]. Chin J Endocrinol Metab, 2008, 24(2): 123-125.